Sustained Release of FGF-21 from a Genetically Engineered Injectable Depot for the Treatment of Type 2 Diabetes

被引：0
|
作者：
Gilroy, Caslin A.
Chilkoti, Ashutosh
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1092-P
引用
收藏
页码：A289 / A289
页数：1
相关论文
共 50 条
  • [1] Exenatide Treatment Decreases the Circulating FGF-21 in Patients with Newly Diagnosed Type 2 Diabetes
    Hu, Yanjin
    Liu, Jia
    Xu, Yuan
    Wang, Guang
    DIABETES, 2016, 65 : A274 - A274
  • [2] Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia
    Gilroy, C. A.
    Capozzi, M. E.
    Varanko, A. K.
    Tong, J.
    D'Alessio, D. A.
    Campbell, J. E.
    Chilkoti, A.
    SCIENCE ADVANCES, 2020, 6 (35):
  • [3] A genetically engineered thermally responsive sustained release curcumin depot to treat neuroinflammation
    Sinclair, S. Michael
    Bhattacharyya, Jayanta
    McDaniel, Jonathan R.
    Gooden, David M.
    Gopalaswamy, Ramesh
    Chilkoti, Ashutosh
    Setton, Lori A.
    JOURNAL OF CONTROLLED RELEASE, 2013, 171 (01) : 38 - 47
  • [4] Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus
    Zhang, Mei
    Liu, Ying
    Xiong, Zhong-yun
    Deng, Zhi-yong
    Song, Hao-lan
    An, Zhen-Mei
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (03) : 220 - 224
  • [5] SERUM FGF-21 LEVELS ARE ASSOCIATED WITH ARTERIAL STIFFNESS IN KOREAN MALE WITH TYPE 2 DIABETES
    Shin, J. Y.
    Huh, J. H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S61 - S61
  • [6] Serum FGF-21 Levels in Type 2 Diabetic Patients
    Cheng, Xingbo
    Zhu, Bei
    Jiang, Fusong
    Fan, Huaying
    ENDOCRINE RESEARCH, 2011, 36 (04) : 142 - 148
  • [7] Synergistic effect of canine FGF-21 combined with insulin in the treatment of canine diabetes
    Sun, Wenying
    Wang, Yaoqun
    Liu, Ziran
    Wu, Qing
    Guo, Xiaochen
    Li, Zhitong
    Li, Xinyu
    Shi, Chunxu
    Gao, Rui
    Bai, Lin
    Wang, Jingming
    Zhang, Yuhan
    Li, Lu
    Ren, Guiping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [8] Fibroblast Growth Factor-21 (FGF-21) as a Novel Marker of Metabolic Complications in Type 2 Diabetes and Obesity
    Matuszek, Beata
    Lenart-Lipinska, Monika
    Duma, Dariusz
    Solski, Janusz
    Nowakowski, Andrzej
    DIABETES, 2010, 59 : A562 - A562
  • [9] Plasma FGF-21 levels in type 2 diabetic patients with ketosis
    Li, Ling
    Yang, Gangyi
    Ning, Heu
    Yang, Mengliu
    Liu, Hua
    Chen, Wenwen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 209 - 213
  • [10] Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes Mellitus
    Chen, W. -W.
    Li, L.
    Yang, G. -Y.
    Li, K.
    Qi, X. -Y.
    Zhu, W.
    Tang, Y.
    Liu, H.
    Boden, G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (01) : 65 - 68
12345